McKesson stock trades at EUR 857.50, 0.84 percent below its high

Published on 10/13/2026 at 16:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

McKesson nears its 52-week high of EUR 864.80. McKesson stock costs EUR 857.50 on October 13, 2026, 0.84 percent below its high.

Price near yearly high

Lang & Schwarz quoted McKesson 0.84 percent below its yearly high on October 13, 2026.
McKesson is scheduled to report second-quarter fiscal 2027 results on November 4, 2026.
McKesson stock costs EUR 857.50 at Lang & Schwarz on October 13, 2026 at 4:03 p.m. CEST, 0.84 percent below the 52-week high.

Aquarellbild einer Skyline mit Bürotürmen am Fluss im Sonnenuntergangslicht — Aquarellmalerei zeigt eine Stadtsilhouette am Firmensitz-Standort von McKesson Corporation ISIN US58155Q1031 bei warmem Sonnenuntergangslicht heute, Illustration mit AI erstellt.

McKesson (ISIN US58155Q1031) was trading at EUR 857.50 at Lang & Schwarz on October 13, 2026 at 4:03 p.m. CEST, 0.84 percent below its 52-week high of EUR 864.80. The narrow gap to the yearly peak makes the stock position the central market figure for investors in Germany.

Results date is November 4

McKesson is scheduled to report its second-quarter fiscal 2027 results on November 4, 2026, according to Simply Wall St. The date gives the market a defined checkpoint after McKesson reported first-quarter fiscal 2027 revenue of USD 105.38 billion, up 7.70 percent year over year, in figures published by MarketBeat.

Stock stays near its high

The current EUR 857.50 price is EUR 7.30 below the EUR 864.80 52-week high and EUR 242.30 above the EUR 615.20 low. That places the quote close to the upper end of its EUR 615.20 to EUR 864.80 annual range.

McKesson had a market capitalization of USD 112.4 billion and a price-to-earnings ratio of 25.64 as of October 13, 2026. Trading volume stood at 61,243 shares against an average volume of 918,321 shares, while the NYSE listing was quoted at USD 959.92 at 2:09 p.m. UTC, equivalent to 10:09 a.m. ET.

Valuation and industry comparison

McKesson's quarterly dividend yield was 0.01 percent on the primary-market quote. Cardinal Health traded at USD 237.44 on October 13, 2026, with a price-to-earnings ratio of 32.81 and a market capitalization of USD 55.6 billion. McKesson therefore carried a lower reported earnings multiple than Cardinal Health, while its market value was larger by USD 56.8 billion.

Trading position remains elevated

McKesson's position near the 52-week high leaves the November 4 reporting date as the next clearly defined valuation checkpoint. The combination of a EUR 857.50 Lang & Schwarz quote, a EUR 864.80 yearly high and USD 112.4 billion in market value gives investors three concrete levels for tracking the stock.

The further course of trading is shown by the continuously updated real-time quote of McKesson stock.